Meadow Creek Investment Management’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$311K Hold
8,316
0.01% 884
2019
Q2
$363K Hold
8,316
0.01% 829
2019
Q1
$355K Hold
8,316
0.01% 814
2018
Q4
$372K Hold
8,316
0.01% 751
2018
Q3
$570K Buy
+8,316
New +$535K 0.01% 674
2018
Q2
Sell
-6,496
Closed -$299K 1311
2018
Q1
$299K Hold
6,496
0.01% 847
2017
Q4
$300K Buy
6,496
+1,008
+18% +$46.3K 0.01% 862
2017
Q3
$247K Buy
5,488
+616
+13% +$26.3K 0.01% 852
2017
Q2
$191K Buy
4,872
+2,212
+83% +$83.6K ﹤0.01% 884
2017
Q1
$101K Buy
2,660
+28
+1% +$1.09K ﹤0.01% 947
2016
Q4
$97K Buy
+2,632
New +$94.1K ﹤0.01% 935

Other funds holding AVNS

Meadow Creek Investment Management's AVNS Position: Q3 2019 in Review

Meadow Creek Investment Management held its Avanos Medical (AVNS) position steady in Q3 2019 at 8,316 shares worth $311K. The position accounts for 0.01% of the portfolio, ranked #884.

Meadow Creek Investment Management first reported a position in AVNS in Q4 2016 and has held it in 11 quarters since. The position peaked at $570K in Q3 2018. 290 funds tracked by Wall St. Rank hold AVNS as of Q3 2019.

  • Meadow Creek Investment Management held 8,316 shares of Avanos Medical worth $311K as of Q3 2019.
  • Meadow Creek Investment Management left its Avanos Medical share count unchanged in Q3 2019.
  • Avanos Medical made up 0.01% of Meadow Creek Investment Management's portfolio in Q3 2019, its #884 holding.
  • Meadow Creek Investment Management first reported a position in Avanos Medical in Q4 2016 and has held it in 11 quarters since.
  • Meadow Creek Investment Management's Avanos Medical position peaked at $570K in Q3 2018.
  • 290 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2019.

Based on Meadow Creek Investment Management's 13F filing for Q3 2019, filed 14 Nov 2019.